Search for: "Takeda Pharmaceutical Company Limited"
Results 1 - 20
of 43
Sorted by Relevance
|
Sort by Date
1 Aug 2019, 2:14 am
Earlier this year, the UK courts considered the validity of Genentech's patent for Taltz, an anti-IL-17 monoclonal antibody (IPKat post here), and last month, the courts considered Pfizer's request for an Arrow declaration relating to Roche's monoclonal antibody drug Avastin (bevacizumab) (IPKat post here).The latest UK High Court patent decision (Takeda v Roche [2019] EWHC 1911) relates to another pair of pharmaceutical company giants… [read post]
21 May 2015, 4:29 am
Takeda Pharmaceutical Co. is attempting to settle nearly 8,000 Actos lawsuits across the United States by agreeing to pay $2.3 billion. [read post]
30 Jun 2014, 7:12 pm
Takeda Pharmaceutical Company Limited 13-1236 Issue: Whether the “freely given” standard for the amendment of pleading embodied in Federal Rule of Civil Procedure 15(a), and espoused in Foman v. [read post]
23 Jan 2012, 7:48 am
Manufactured by Takeda Pharmaceutical Company Limited and co-marketed in the United States by Eli Lilly and Company, Actos is a medication that is prescribed with diet changes and exercise to help regulate blood sugars for patients suffering from Type II diabetes. [read post]
29 Apr 2015, 6:35 am
Takeda Pharmaceutical Co. has announced today that it will pay more than $2.4 billion to settle the pending Actos lawsuits over bladder cancer claims. [read post]
25 Mar 2013, 1:29 pm
., and Takeda Pharmaceuticals Company Limited, of Deerfield, Ill. [read post]
29 Apr 2019, 1:55 pm
Those drug injury lawsuits allege that the drug company Takeda failed to warn Uloric users about the increased risks of heart attacks and strokes. [read post]
3 Mar 2012, 6:48 am
(But not the two new huge drug cases: Boehringer Ingelheim, maker of Pradaxa, is in Connecticut, while Takeda, maker of Actos, is in Illinois.) [read post]
1 Dec 2017, 11:35 am
Bard in Q2 2017 helped increase the value of deals.[27] Takeda Pharmaceutical Company acquired ARIAD Pharmaceuticals Inc for $5.2 billion to expand its oncology business. [read post]
18 Jan 2024, 9:16 am
Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, and Takeda Pharmaceuticals America, Inc.) sued to enjoin Defendants from marketing generic versions on the basis of inducing and/or contributorily infringing various patents, including U.S. [read post]
15 Jun 2014, 6:18 pm
Legal Reasoning (Prost, Plager, Chen)BackgroundPrevacid® SoluTab™Takeda Pharmaceutical Company Limited [et al.] [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/6: Takeda Pharmaceutical Company Ltd. and Takeda Pharmaceuticals North America Inc. v. [read post]
24 May 2012, 4:23 am
We (and a whole bunch of other lawyers) assume that Takeda Pharmaceuticals will argue that the statute of limitations began to run on June 15, 2011, when the FDA issued an updated warning that one year of Actos use increases the risk of bladder cancer by more than 40%. [read post]
15 Nov 2017, 8:00 am
District Court Rules That Attorney-Client Privilege Applied in Insurance Coverage Lawsuit $9 Billion Actos Damage Award Against Takeda and Lilly is Upheld $90 Million Settlement Paid by Pharmaceutical Company For Its Unfair and Deceptive Promotion of Diabetes Drug The post U.S. [read post]
30 Mar 2015, 12:18 pm
Takeda Pharmaceuticals North America, Inc., No. [read post]
10 Feb 2014, 9:50 pm
Long Teva and several other generic pharmaceutical companies each submitted an ANDA seeking approval to market a generic version of Lyrica, for treating seizures and pain. [read post]
7 Feb 2019, 6:00 am
The most prominent of these deals was the takeover of Shire plc by Takeda Pharmaceutical Company Limited. [read post]
23 Dec 2009, 12:40 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Zyprexa (Olanzapine) – UK: Court of Appeal upholds Justice Floyd’s decision finding Olanzapine patent valid: Dr Reddy’s Laboratories v Eli Lilly (EPLAW) (IPKat) (Managing IP) (PatLit) (GenericsWeb) France: Pharma trade marks under threat - Senate and National Assembly approve law that would allow generic… [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess Copyright)… [read post]
23 Nov 2015, 8:00 am
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
